Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Hepatitis B × Clear all

Phase

Phase 4 4 Phase 2 2 Phase NA 1 Phase 3 1 Phase 1 1

Status

Completed 3 Terminated 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 124 Carcinoma, Non-Small-Cell Lung 90 Colorectal Neoplasms 82 Carcinoma, Hepatocellular 65 Stomach Neoplasms 60 Rectal Neoplasms 48 Neoplasms 47 Lung Neoplasms 41 Nasopharyngeal Carcinoma 37 Leukemia, Myeloid, Acute 37 Lymphoma, Large B-Cell, Diffuse 36 Colonic Neoplasms 36 Prostatic Neoplasms 33 Neoplasm Metastasis 33 Uterine Cervical Neoplasms 31 Multiple Myeloma 29 Lymphoma, Follicular 29 Esophageal Neoplasms 29 Ovarian Neoplasms 27 Lymphoma 27 Pancreatic Neoplasms 26 Leukemia 26 Recurrence 21 Brain Neoplasms 20 Lymphoma, Non-Hodgkin 18 Head and Neck Neoplasms 18 Urinary Bladder Neoplasms 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Lymphoma, Mantle-Cell 16 Leukemia, Lymphocytic, Chronic, B-Cell 16

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02186574 2019-12-12

Tenofovir to Prevent HBV Reactivation

University Health Network, Toronto

Phase 3 Unknown

Hepatitis B, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡